Drug
Askp1240
Askp1240: highest development phase Phase 2, developed by Astellas. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASKP1240 NCT01585233 | Phase 2 | Psoriasis |
| ASKP1240 NCT01582399 | Phase 1 | Pharmacokinetics of ASKP1240 |
Latest
No recent events.
Follow Askp1240 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.